Risk of Second Malignancy after Treatment for Hodgkin Lymphoma

Date & Time(s)

Contact

430 East 67th Street
Room RRL - 116

Speaker(s)

Flora van Leeuwen, PhD
Head Department of Epidemiology / Group leader
The Netherlands Cancer Institute